GlassScriptPhysician profile
Daniel J Owen
NPI 1942753918
$3,872.73
in general payments reported to CMS, 2019-2025
34 companies · $91.46 in 2025
The $91.46 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.77 · 2020: $455 · 2021: $719 · 2022: $967 · 2023: $921 · 2024: $663 · 2025: $91.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,675.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,479.17 | 2021-2024 | |
| Novo Nordisk INC | $376.70 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $329.79 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.43 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $212.78 | 2021-2024 | Jardiance |
| Allergan, INC. | $174.89 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $137.37 | 2022 | |
| Astellas Pharma US INC | $105.31 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $94.53 | 2022-2024 | |
| Boston Scientific Corporation | $72.40 | 2022-2025 | Watchman Access System, Watchman Flx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.46 | 2019-2024 | Xifaxan |
| Abbott Laboratories | $52.99 | 2022-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $48.41 | 2020-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $47.49 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $38.88 | 2023 | Optimizer |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $31.87 | 2020-2023 | |
| Nalu Medical, INC. | $31.86 | 2025 | Nalu Neurostimulation System |
| Organon LLC | $29.58 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.25 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $24.94 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.32 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $22.99 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $20.30 | 2023 | Rexulti |
| Mylan Specialty L.P. | $20.05 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.46 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $18.57 | 2022 | |
| Medtronic, INC. | $15.31 | 2023 | Kyphon Express II Kyphopak Tray |
| Merck Sharp & Dohme LLC | $15.11 | 2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Adlon Therapeutics L.P. | $14.32 | 2020 | |
| Esperion Therapeutics, INC. | $14.26 | 2020 | |
| Xeris Pharmaceuticals, INC. | $13.49 | 2023 | Gvoke Hypopen |
| Amgen INC. | $13.30 | 2023 | Prolia, Evenity |
| Actelion Pharmaceuticals US, INC. | $13.14 | 2024 | Uptravi, Opsumit |
| Kowa Pharmaceuticals America, INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.